GlobeNewswire 05/12/2025 Ascentage Pharma Announces Global Registrational Phase III Study of Olverembatinib in First-Line Tre...
GlobeNewswire 03/12/2025 Actithera appoints radiopharmaceutical pioneer Dr. Darshan Dalal as Chief Medical Officer
GlobeNewswire 01/12/2025 AIM ImmunoTech to Participate in Live ‘Fireside’ Chat on Virtual Investor Closing Bell Series
GlobeNewswire 01/12/2025 Ascentage Pharma to Host Webcast Highlighting Key Data from ASH 2025
GlobeNewswire 27/11/2025 HUTCHMED Highlights Clinical Data to be Presented at the 2025 ESMO Asia Congress and the 2025 ASH An...
GlobeNewswire 26/11/2025 Vera Therapeutics Appoints Veteran Biotech Executive James R. Meyers to its Board of Directors
GlobeNewswire 25/11/2025 Ascentage Pharma Announces Publication of Olverembatinib Phase Ib Safety, Efficacy and Novel Mechani...
TeleTrader 21/11/2025 AstraZeneca to invest $2B in Maryland facilities
GlobeNewswire 19/11/2025 Spherix Global Insights Reports Rapidly Evolving U.S. PNH Market as Ultomiris Prescriptions Reach Pa...
GlobeNewswire 19/11/2025 Ascentage Pharma to Participate in Three Upcoming Investor Conferences in December 2025
GlobeNewswire 14/11/2025 Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights 
GlobeNewswire 13/11/2025 New Guide Helps Patients Navigate Genetic Testing for Advanced Prostate Cancer
GlobeNewswire 12/11/2025 Artelo Biosciences Provides Business Update and Reports Third Quarter 2025 Financial Results
GlobeNewswire 10/11/2025 FibroGen Reports Third Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire 10/11/2025 Voyager Reports Third Quarter 2025 Financial and Operating Results
GlobeNewswire 10/11/2025 Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS...
GlobeNewswire 09/11/2025 Medera Presents Late-Breaking Data from First-In-Human Gene Therapy Trial for Heart Failure with Pre...
GlobeNewswire 07/11/2025 Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update
TeleTrader 06/11/2025 Europe closes lower after BoE's decision, earnings
GlobeNewswire 06/11/2025 Novel Pipeline Activity Signals Hope in Systemic Sclerosis, as Rheumatologists Anticipate First Real...
GlobeNewswire 06/11/2025 Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics
GlobeNewswire 06/11/2025 Axsome Therapeutics Acquires Subtype Selective GABA-A Receptor Positive Allosteric Modulator AZD7325...
TeleTrader 06/11/2025 Europe opens mostly in red with BoE, earnings in focus
TeleTrader 06/11/2025 AstraZeneca’s Q3 revenue grows 12% to $15.2B
GlobeNewswire 05/11/2025 Royalty Pharma Reports Third Quarter 2025 Results